Sanofi Misled Buyers About Pain Relief Patches, Suit Says
By Celeste Bott · May 3, 2021, 7:30 PM EDT
A proposed class of consumers accused Sanofi US Corp. of misrepresenting the strength and longevity of the pain relief provided by its over-the-counter external analgesic patches under the Aspercreme brand in an...
To view the full article, register now.
Try a seven day FREE Trial
Already a subscriber? Click here to login